Insider Transactions in Q1 2024 at Sellas Life Sciences Group, Inc. (SLS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2024
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+31.56%
|
-
|
|
Jan 22
2024
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
Robert Francomano Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+32.83%
|
-
|
|
Jan 22
2024
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.59%
|
-
|
|
Jan 22
2024
|
Katherine Bach Kalin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+41.38%
|
-
|
|
Jan 22
2024
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.99%
|
-
|
|
Jan 22
2024
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+36.18%
|
-
|
|
Jan 22
2024
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
159,000
+29.7%
|
-
|